BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

817 related articles for article (PubMed ID: 12894226)

  • 1. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.
    Hastak K; Gupta S; Ahmad N; Agarwal MK; Agarwal ML; Mukhtar H
    Oncogene; 2003 Jul; 22(31):4851-9. PubMed ID: 12894226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB.
    Lee MH; Han DW; Hyon SH; Park JC
    Apoptosis; 2011 Jan; 16(1):75-85. PubMed ID: 20963498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate.
    Hastak K; Agarwal MK; Mukhtar H; Agarwal ML
    FASEB J; 2005 May; 19(7):789-91. PubMed ID: 15764647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells.
    Ling MT; Wang X; Ouyang XS; Xu K; Tsao SW; Wong YC
    Oncogene; 2003 Jul; 22(29):4498-508. PubMed ID: 12881706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage.
    Nabha SM; Mohammad RM; Dandashi MH; Coupaye-Gerard B; Aboukameel A; Pettit GR; Al-Katib AM
    Clin Cancer Res; 2002 Aug; 8(8):2735-41. PubMed ID: 12171907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis.
    Gupta S; Hastak K; Afaq F; Ahmad N; Mukhtar H
    Oncogene; 2004 Apr; 23(14):2507-22. PubMed ID: 14676829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma.
    Nihal M; Ahmad N; Mukhtar H; Wood GS
    Int J Cancer; 2005 Apr; 114(4):513-21. PubMed ID: 15609335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation.
    Roy AM; Baliga MS; Katiyar SK
    Mol Cancer Ther; 2005 Jan; 4(1):81-90. PubMed ID: 15657356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
    Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
    Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited role of N-terminal phosphoserine residues in the activation of transcription by p53.
    Jackson MW; Agarwal MK; Agarwal ML; Agarwal A; Stanhope-Baker P; Williams BR; Stark GR
    Oncogene; 2004 May; 23(25):4477-87. PubMed ID: 15064747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells.
    Gupta S; Hussain T; Mukhtar H
    Arch Biochem Biophys; 2003 Feb; 410(1):177-85. PubMed ID: 12559991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143.
    Li Y; Raffo AJ; Drew L; Mao Y; Tran A; Petrylak DP; Fine RL
    Cancer Res; 2003 Apr; 63(7):1527-33. PubMed ID: 12670900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
    Ray S; Almasan A
    Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3-gallate.
    Afaq F; Adhami VM; Ahmad N; Mukhtar H
    Oncogene; 2003 Feb; 22(7):1035-44. PubMed ID: 12592390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells.
    Sun SY; Yue P; Wu GS; El-Deiry WS; Shroot B; Hong WK; Lotan R
    Oncogene; 1999 Apr; 18(14):2357-65. PubMed ID: 10327056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
    Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
    Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells.
    Ahmad N; Gupta S; Mukhtar H
    Arch Biochem Biophys; 2000 Apr; 376(2):338-46. PubMed ID: 10775421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Green tea polyphenol epigallocatechin-3 gallate induces apoptosis of proliferating vascular smooth muscle cells via activation of p53.
    Hofmann CS; Sonenshein GE
    FASEB J; 2003 Apr; 17(6):702-4. PubMed ID: 12586742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells.
    Chen C; Shen G; Hebbar V; Hu R; Owuor ED; Kong AN
    Carcinogenesis; 2003 Aug; 24(8):1369-78. PubMed ID: 12819184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indole-3-carbinol inhibits protein kinase B/Akt and induces apoptosis in the human breast tumor cell line MDA MB468 but not in the nontumorigenic HBL100 line.
    Howells LM; Gallacher-Horley B; Houghton CE; Manson MM; Hudson EA
    Mol Cancer Ther; 2002 Nov; 1(13):1161-72. PubMed ID: 12479697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.